Showing 661 - 680 results of 42,170 for search '(( 50 ((ns decrease) OR (((we decrease) OR (a decrease)))) ) OR ( a point decrease ))', query time: 0.95s Refine Results
  1. 661
  2. 662

    Doctors’ perceptions of the impact of upfront point-of-care testing in the emergency department by Lara Nicole Goldstein (6082706)

    Published 2018
    “…Upfront, protocolised, POC testing is a low-input, high-yield intervention that decreased treatment time and satisfied doctors.…”
  3. 663
  4. 664

    TIP47 is involved in HCV RNA replication <i>via</i> interaction with NS5A. by Dorothee A. Vogt (247917)

    Published 2013
    “…Values are expressed as fold increase of luciferase (RLU) per well, over a 4 h time point (mean ± standard deviation; n = 3, *P<0.05, **P<0.01, ***P<0.001). …”
  5. 665
  6. 666
  7. 667
  8. 668
  9. 669

    Optimal screening time point for a single colonoscopy program in the US. by Viktor Zaika (18611072)

    Published 2024
    “…<p><b>(A)</b> Reduction in life years lost, CRC incidence, mortality and total costs for different time points of a single screening colonoscopy with 100% adherence. …”
  10. 670
  11. 671

    Table_1_When and Why Did Human Brains Decrease in Size? A New Change-Point Analysis and Insights From Brain Evolution in Ants.XLSX by Jeremy M. DeSilva (7247009)

    Published 2021
    “…<p>Human brain size nearly quadrupled in the six million years since Homo last shared a common ancestor with chimpanzees, but human brains are thought to have decreased in volume since the end of the last Ice Age. …”
  12. 672

    Optimal time points for a three-colonoscopy screening program in the US. by Viktor Zaika (18611072)

    Published 2024
    “…Selected model parameters were increased and decreased by up to 50%. Dashed lines indicate average optimal points obtained for nominal simulations. …”
  13. 673
  14. 674

    GluN2A(D731N) decreases channel open probability. by Kai Gao (120150)

    Published 2017
    “…The di-heteromeric mutant (2A-D731N) and tri-heteromeric receptors with two-copies of the mutant subunit (D731N/D731N) showed a prolonged inhibition rate, reflecting a decreased channel open probability. …”
  15. 675
  16. 676
  17. 677

    A Novel Highly Potent Autotaxin/ENPP2 Inhibitor Produces Prolonged Decreases in Plasma Lysophosphatidic Acid Formation <i>In Vivo</i> and Regulates Urethral Tension by Hiroshi Saga (584103)

    Published 2014
    “…To date, several autotaxin/ENPP2 inhibitors have been reported; however, none were able to completely and continuously inhibit autotaxin/ENPP2 <i>in vivo</i>. In this study, we report the discovery of a highly potent autotaxin/ENPP2 inhibitor, ONO-8430506, which decreased plasma lysophosphatidic acid formation.…”
  18. 678
  19. 679
  20. 680